NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 1 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $408,000 | -39.1% | 323,973 | +0.5% | 0.00% | -100.0% |
| Q3 2016 | $670,000 | -70.3% | 322,334 | +3.9% | 0.00% | -50.0% |
| Q2 2016 | $2,254,000 | +58.5% | 310,110 | +12.5% | 0.00% | +100.0% |
| Q1 2016 | $1,422,000 | -46.8% | 275,537 | -13.6% | 0.00% | -66.7% |
| Q4 2015 | $2,675,000 | -37.5% | 318,815 | -47.3% | 0.00% | -40.0% |
| Q3 2015 | $4,279,000 | -4.7% | 605,211 | +50.2% | 0.01% | 0.0% |
| Q2 2015 | $4,488,000 | +132.4% | 402,853 | +72.5% | 0.01% | +150.0% |
| Q1 2015 | $1,931,000 | +126.1% | 233,473 | +62.1% | 0.00% | +100.0% |
| Q4 2014 | $854,000 | +49.6% | 144,032 | +5.2% | 0.00% | 0.0% |
| Q3 2014 | $571,000 | -4.2% | 136,931 | +6.1% | 0.00% | 0.0% |
| Q2 2014 | $596,000 | +1.2% | 129,082 | -0.7% | 0.00% | 0.0% |
| Q1 2014 | $589,000 | -26.1% | 129,941 | -16.6% | 0.00% | 0.0% |
| Q4 2013 | $797,000 | +133.7% | 155,719 | +43.8% | 0.00% | – |
| Q3 2013 | $341,000 | -94.3% | 108,266 | -96.3% | 0.00% | -100.0% |
| Q2 2013 | $6,012,000 | – | 2,932,620 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
| BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
| Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
| HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
| WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
| Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
| AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
| Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
| Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |